Terms: = Head and neck cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Clinical Outcome
6 results:
1. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
2. Expression of brca1 and ERCC1 as predictive clinical outcome after radiochemotherapy in patients with locoregionally moderate-advanced nasopharyngeal carcinoma.
Xu S; Yu Y; Rong J; Hu D; Zhang L; Fu S; Yang H; Fan J; Yang L; Wu J
Oncotarget; 2017 May; 8(19):31355-31367. PubMed ID: 28404895
[TBL] [Abstract] [Full Text] [Related]
3. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract] [Full Text] [Related]
4. DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.
Zhou Q; Zou BW; Xu Y; Xue JX; Meng MB; Liu FJ; Deng L; Ma DY; Ao R; Lu Y
Tumour Biol; 2015 Mar; 36(3):1539-48. PubMed ID: 25374063
[TBL] [Abstract] [Full Text] [Related]
5. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.
Kim TH; Park YJ; Lim JA; Ahn HY; Lee EK; Lee YJ; Kim KW; Hahn SK; Youn YK; Kim KH; Cho BY; Park DJ
Cancer; 2012 Apr; 118(7):1764-73. PubMed ID: 21882184
[TBL] [Abstract] [Full Text] [Related]
6. [Nasosinusal adenocarcinoma: molecular and genetic analysis by MLPA].
Llorente JL; Aldama P; Alvarez-Marcos C; Escudero J; Alonso-Guervós M; Fresno F; Suárez C; Hermsen M
Acta Otorrinolaringol Esp; 2008 Apr; 59(4):151-8. PubMed ID: 18447972
[TBL] [Abstract] [Full Text] [Related]
